Volume 02 Issue 12-2022 21 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi ABSTRACT In order to introduce pharmaceutical care (PC) to ophthalmic patients, we studied the statistics of diseases, conducted an assortment analysis of drugs used in ophthalmic diseases. The analysis of the purchase of drugs was carried out, the index of renewal and consumption of medicines used in ophthalmic practice was considered. Based on the analysis, a AF model has been developed that will improve the effectiveness and safety of drug therapy, as well as improve the quality of life of the patient by integrating the efforts of medical, pharmaceutical specialists and patients. KEYWORDS Pharmaceutical care, ophthalmology, medicines, eye diseases INTRODUCTION Today, the task of optimizing the work of the pharmaceutical industry can be solved by improving the provision of the population, which can be implemented taking into account a large number of Research Article SYSTEM MODELING OF PHARMACEUTICAL CARE IN OPHTHALMOLOGICAL PRACTICE AND ORGANIZATIONAL AND ECONOMIC JUSTIFICATION OF THE MAIN DIRECTIONS OF ITS IMPLEMENTATION Submission Date: December 20, 2023, Accepted Date: December 25, 2023, Published Date: December 30, 2023 Crossref doi: https://doi.org/10.37547/ajbspi/Volume02Issue12-04 Shodmanov Shoyusuf Furkatovich Competitor of the Tashkent Pharmaceutical Institute, Uzbekistan Umarova Shakhnoza Ziyatovna Pharmaceutical Institute of Education and Research, Ph.D. prof., Uzbekistan Journal Website: https://theusajournals. com/index.php/ajbspi Copyright: Original content from this work may be used under the terms of the creative commons attributes 4.0 licence. https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi https://theusajournals.com/ https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://theusajournals.com/index.php/ajbspi https://theusajournals.com/index.php/ajbspi Volume 02 Issue 12-2022 22 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi factors, and by developing the field of pharmaceutical services, which depends on the qualifications of employees and the capabilities of the organizations themselves [1]. Pharmaceutical care is a complex integrated process of cooperation, which is aimed at the timely detection, prevention and solution of problems associated with the use of medicines [2]. The main goal of pharmaceutical care is to optimize the health status and quality of life of patients, as well as to achieve further positive clinical results [2]. The purpose of the study . To develop a model for optimizing systemic pharmaceutical care in ophthalmic practice. RESULTS OF THE STUDY To solve the formulated problem and in accordance with the goals of optimizing pharmaceutical care , a model was developed. The goal of management is to improve the AF of patients with ophthalmic diseases. The main result of the management of this model is to improve the quality of drug provision for ophthalmic patients. The developed model is characterized by the interconnectedness of management levels and functional management processes. The main part of the developed model includes the management of the pharmaceutical care system, implemented through the organizational and economic management mechanism, which is a complex of certain elements that provide the necessary final result. The main goal of this model includes the management and optimization of pharmaceutical care and has 2 levels of its implementation: 1st level - these are medical organizations, starting with a visit to a doctor to the correct diagnosis of the disease and prescribing the necessary medicines, respectively, taking into account the patient's solvency. This stage also includes self-treatment of patients on the advice of friends, based on past experience, as well as the preferences of the patient himself. Stage 2 or level of pharmacy organizations that provide pharmaceutical assistance, the duty of this stage is to form a need, while studying consumer interaction, satisfaction, loyalty. To perform the above functions, both levels must study the treatment protocols, form a list of essential medicines. Both levels of organization include the professionalism of the staff, the patient's ability to pay, the effectiveness and availability of pharmacotherapy. Each level of management is interconnected. Outcome of the Pharmaceutical Care Enhancement and Improvement Model ( Figure 5.1) . For the purpose of the effective functioning of the proposed model, an organizational and economic justification of the main directions for the implementation of the model, which consists of 5 stages, has been developed. Stage 1 Analysis of the state of pharmaceutical care for patients with problems of the eyes and adnexa. Below are the main components of this stage: - Analysis of the pharmaco-epidemiology of ophthalmic diseases to determine accurate statistics and prognosis. - Analysis of the range of drugs used in ophthalmic diseases. - Analysis of the volume of the pharmaceutical market of medicines used in ophthalmic diseases. - Study of demand and actual consumption of medicines used in ophthalmic diseases. During the first stage, we collect basic data for analysis. 2nd stage. Organizational and economic approaches to the study of consumers, which consist of: 1. Processing of statistical data of ophthalmic diseases for predicting morbidity. https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi Volume 02 Issue 12-2022 23 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi 2. Marketing analysis of the assortment, as well as graphical analysis of the results. 3. Analysis of the volume of the pharmaceutical market and interpretation of the results. 4. Assessment of the economic availability of medicines. 5. Assessment of the need for medicines. 6. Assessment of drug consumption. The economic results of this stage consist of: 1. The actual spread of the disease. 2. The total number of the range of medicines. 3. The actual volume of import of medicines. 4. Actual demand and consumption of medicines. 5. Accuracy and reliability of forecasting. 3-stage. Stage comparison: 1. Compare the actual consumption of drugs with the actual size of the pharmaceutical market. 2. Compare prescribed medicines with standards of care by reviewing patient history. The results of the 3rd stage contribute to the definition of need and the rational use of medicines. 4-stage. Pharmaco -economic evaluation of therapy used in ophthalmic practice consists of: 1. Conduct a systematic review of the scientific literature based on evidence-based medicine on clinical effectiveness 2. Systematic review of scientific literature on cost- effectiveness 3. Analysis of the cost-effectiveness of treatment The results of the 4th stage contribute to the formation of a list of essential medicines, the improvement of treatment standards, as well as clinical recommendations, and the rational use of the state budget . Figure 5.2 shows a diagram of the organizational and economic justification model for the main directions of implementation. 5-stage. The development of optimal pharmaceutical care for diseases of the eye and adnexa consists of: 1. Based on the statistical processing of diseases, develop a program 2. Develop a disease forecasting program 3. Based on the forecast, determine the need for medicines used in ophthalmic practice As a result of the developed model, it is possible to improve pharmaceutical care for patients with diseases of the eyes and adnexa. https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi Volume 02 Issue 12-2022 24 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi Rice. 1 Model for improving pharmaceutical care for ophthalmic patients 1 level Medical organization Level 2 pharmacy organization Role of Systemic Pharmaceutical Care Patient with eye problem Outcome: Increases and improvements in the organization of pharmaceutical care Contacting a doctor 1. Diagnosis of the patient 2. Choice of rational pharmacotherapy 3. The decision to take pharmacotherapy for p Advice from friends Self-treatment Past experience Patient preferences Waiting for the result of pharmacotherapy Professionalism of pharmacists Create demand for medicines Explore: 1 . Consumer interaction 2. Customer satisfaction 3. Consumer loyalty Disease prevalence analysis Study of treatment protocols Formation of a list of basic medicines https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi Volume 02 Issue 12-2022 25 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi Rice. 2. Organizational and economic justification of the main directions for the implementation of the model Findings Organizational and economic substantiation of the main directions of the model implementation 1. Analysis of the state of pharmaceutical care for patients with problems of the eyes and adnexa Analysis of the pharmacoepidemiology of ophthalmic diseases Analysis of the range of medicinal used ophthalmic diseases Analysis of the procurement of drugs used in coronary artery disease II Organizational and economic approaches to the study of consumers 1 Processing of statistical data of ophthalmic diseases 1 Marketing analysis of assortment 2 Graphical analysis III Stage comparison 1. Compare actual drug consumption with actual purchases 2. Compare prescribed medicines with standa Improving pharmaceutical care for patients with diseases of the eyes and adnexa Studying the demand and actual consumption of drugs used in coronary artery disease 1 Analysis of drug procurement 2 Assessing the affordability of medicines 2 Assessment of the need for drugs 3. Assessment of drug consumption V stage. Development of optimal pharmaceutical care for patients with diseases of the eyes and adnexa 1. Develop a program for processing statistical data on the pharmacoepidiology of morbidity 2. Predict further spread of morbidity 3. Develop a program to determine the optimal need for medicines Stage VI Pharmacoeconomic evaluation of therapy used in ophthalmic practice 1. Conduct a systematic review of the scientific literature based on evidence-based medicine on clinical effectiveness 2. Systematic review of scientific literature on economic efficiency 3. Analysis of the cost-effectiveness of treatm Results of the first stage: 1. Collection of basic data for analysis Economic results of the second stage: 1. Actual spread of disease 2. The total number of the range of medicines 3. Actual volume of import of medicines 4. Actual demand and consumption of medicines 5. Accuracy and reliability of forecasting Results of the 3rd stage: 1. Contributes to the definition of need 2. Rational use of medicines Results of the 4th stage 1. Contributes to the formation of the list of essential medicines 2. Contributes to the improvement of treatment standards and clinical guidelines 3. Promotes rational use of the state budget https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi Volume 02 Issue 12-2022 26 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 02 ISSUE 12 Pages: 21-26 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) OCLC – 1121105677 METADATA IF – 5.896 Publisher: Oscar Publishing Services Servi The analysis of the range, pharmacoepidiology of patients with ophthalmic diseases was carried out, the case histories were studied, the analysis of the purchase of medicines used in ophthalmological practice was carried out. Based on these data, a model has been developed to improve pharmaceutical care for ophthalmic patients. The model consists of 2 levels of organization. The first is the medical level of the organization, the second is the pharmaceutical level of the organization. REFERENCES 1. N.N. Zubov, V.I. Kuvakin. Methods of multivariate statistical data analysis in medicine and pharmacy. Tutorial. St. Petersburg-2017. –S.138-150. 2. Belousova O. V., Belousov E. A., Bugaeva A. S. Monitoring the provision of pharmaceutical care to the population of the city of Belgorod // Scientific results of biomedical research 3. Umarova Sh. Z., Shodmanov Sh. F., Sultanbayeva N. M. U. Development of a system management model for the process of providing pharmaceutical care to patients with diseases of the eye and adnexa // Scientific progress as a key factor in the development of the sphere of knowledge. - 2020. - S. 332-337. https://doi.org/10.37547/ajbspi/Volume02Issue12-04 https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION https://www.mendeley.com/search/?page=1&query= https://theusajournals.com/index.php/ajbspi